COVID-19 and diabetes: Can DPP4 inhibition play a role?
- PMID: 32224164
- PMCID: PMC7271223
- DOI: 10.1016/j.diabres.2020.108125
COVID-19 and diabetes: Can DPP4 inhibition play a role?
Conflict of interest statement
Declaration of Competing Interest The author declares no conflict of interest.
Comment in
-
COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications.Diabetes Res Clin Pract. 2020 May;163:108165. doi: 10.1016/j.diabres.2020.108165. Epub 2020 Apr 23. Diabetes Res Clin Pract. 2020. PMID: 32333966 Free PMC article. No abstract available.
-
Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? - GLP-1 might play one too.Diabetes Res Clin Pract. 2020 Jun;164:108160. doi: 10.1016/j.diabres.2020.108160. Epub 2020 Apr 22. Diabetes Res Clin Pract. 2020. PMID: 32333969 Free PMC article. No abstract available.
-
Letter to the editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?".Diabetes Res Clin Pract. 2020 May;163:108163. doi: 10.1016/j.diabres.2020.108163. Epub 2020 Apr 23. Diabetes Res Clin Pract. 2020. PMID: 32333972 Free PMC article. No abstract available.
References
-
- Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
